Skip to main
IBM

IBM (IBM) Stock Forecast & Price Target

IBM (IBM) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 31%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

The positive outlook for IBM's stock is supported by its strong software revenue performance, which reached $9.03 billion, reflecting an 11% year-over-year increase and surpassing analyst expectations. The company anticipates revenue growth exceeding 5% year-over-year for FY26, driven by the focus on its software vertical and an expected increase in free cash flow to $15.70 billion, signifying efficient capital management and operational leverage. Additionally, IBM's total revenues of $19.69 billion, up 9% year-over-year, coupled with the expansion of operating margins, underscore the company's robust execution and resilience in a competitive market.

Bears say

The financial outlook for IBM appears negative due to heightened competition risks, particularly from emerging technologies like Anthropic's Claude Code, which could threaten IBM's legacy system business reliant on COBOL. Additionally, the company's non-GAAP pre-tax margin of 24.1% fell short of both analyst estimates and previous periods, primarily due to workforce rebalancing charges and an unfavorable portfolio mix. Furthermore, IBM's operating cash flow decreased to $4.04 billion from $4.30 billion year-over-year, reflecting challenges in maintaining financial momentum amid evolving industry dynamics.

IBM (IBM) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 31% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IBM and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IBM (IBM) Forecast

Analysts have given IBM (IBM) a Buy based on their latest research and market trends.

According to 13 analysts, IBM (IBM) has a Buy consensus rating as of Apr 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $315.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $315.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IBM (IBM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.